Clariane SELTS:0OPS -3.09%61 Gross Margin % is 92.24% as of Dec. 2025, which is 0% above its 10-year median of 92.07. GuruFocus rates LTS:0OPS with a GF Score™ of 61/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Clariane SE ranks better than 95.39% on this metric.
The historical rank and industry rank for Clariane SE's Gross Margin % or its related term are showing as below:
LTS:0OPS'
s Gross Margin % Range Over the Past 10 Years
Min: 91.68 Med: 92.07 Max: 92.52
Current: 92.11
During the past 13 years, the highestGross Margin % of Clariane SE was 92.52%. The lowest was 91.68%. And the median was 92.07%.
LTS:0OPS's Gross Margin % is ranked better than 95.39% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs LTS:0OPS: 92.11
Clariane SE had a gross margin of 92.24% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Clariane SE was -0.10% per year.
Clariane SE (LTS:0OPS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Clariane SE had a gross margin of 92.24% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Clariane SE Gross Margin % Related Terms
Clariane SE Gross Margin % Historical Data
* Premium members only.
The historical data trend for Clariane SE's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0OPS vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Clariane SE's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Clariane SE's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Clariane SE (LTS:0OPS) has a Gross Margin % of 92.24% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Clariane SE and its competitors. This is near median its historical median of 92.07. Over the past decade, Clariane SE's Gross Margin % has ranged from 91.68 to 92.52. According to the industry distribution chart, Clariane SE ranks #29 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 4.6%.
Is Clariane SE's Gross Margin % too high?
Clariane SE's current Gross Margin % of 92.24% is near median its 10-year median of 92.07. Over the past 10 years, this metric has ranged from a low of 91.68 to a high of 92.52. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Clariane SE's value of 92.24% is 130.1% above this industry median. Based on the distribution chart, Clariane SE ranks #29 out of 629 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #29 out of 629 companies for Gross Margin %. This places Clariane SE in the top 5% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Clariane SE's value of 92.24% is 130.1% above this benchmark. Historically, Clariane SE's own Gross Margin % has ranged from 91.68 to 92.52 over the past decade. While the company's 10-year median is 92.07 vs. the industry median of 40.09, Clariane SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current Gross Margin % of 92.24% is 130.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current Gross Margin % is 92.24%, which is near median its own 10-year median of 92.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (LTS:0OPS) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.10 — trading 64.8% above its estimated fair value. The current Gross Margin % is 92.24%, which is near median its 10-year median of 92.07 and 130.1% above the Healthcare Providers & Services industry median of 40.09. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Clariane SE (LTS:0OPS), the current Gross Margin % is 92.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (LTS:0OPS) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.10 is trading 64.8% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for LTS:0OPS:
Gross Margin %: 92.24% (near median its 10-year median of 92.07)
GF Value™: €2.49 vs. price of €4.10 (64.8% above fair value)
Industry Position: 130.1% above the Healthcare Providers & Services median (#29 of 629)
No single metric tells the full story. See the LTS:0OPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for LTS:0OPS
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OPS has been successfully added to your 
